The National Hospital Seizure Severity Scale: a further development of the Chalfont Seizure Severity Scale.

scientific article published in June 1996

The National Hospital Seizure Severity Scale: a further development of the Chalfont Seizure Severity Scale. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1528-1157.1996.TB00610.X
P698PubMed publication ID8641234
P5875ResearchGate publication ID14559798

P50authorJohn S. DuncanQ6256238
Ley SanderQ6537960
P2093author name stringO'Donoghue MF
P2860cites workStatistical methods for assessing agreement between two methods of clinical measurementQ26778461
P433issue6
P921main subjectseizureQ6279182
P304page(s)563-571
P577publication date1996-06-01
P1433published inEpilepsiaQ5382969
P1476titleThe National Hospital Seizure Severity Scale: a further development of the Chalfont Seizure Severity Scale.
P478volume37

Reverse relations

cites work (P2860)
Q34992393(Cost)-effectiveness of a multi-component intervention for adults with epilepsy: study protocol of a Dutch randomized controlled trial (ZMILE study)
Q33787985A Retrospective Cohort Study to Assess Patient and Physician Reported Outcome Measures After Decompressive Hemicraniectomy for Malignant Middle Cerebral Artery Stroke
Q40827463A randomized controlled trial of the ketogenic diet in refractory childhood epilepsy
Q77530518Adjunctive therapy in epilepsy with new antiepileptic drugs: is it of any value?
Q51083233Affective aggression in patients with temporal lobe epilepsy: a quantitative MRI study of the amygdala.
Q93029514An evaluation of the psychosocial impact of epilepsy on marriage in the United Kingdom
Q41506430Assessing changes over time in temporal lobectomy: outcome by scoring seizure frequency
Q46938038Assessing severity of epilepsy in children: preliminary evidence of validity and reliability of a single-item scale.
Q48225021Asymmetry of cerebral blood flow measured with three-dimensional pseudocontinuous arterial spin-labeling mr imaging in temporal lobe epilepsy with and without mesial temporal sclerosis
Q37340458Automatic Vagus Nerve Stimulation Triggered by Ictal Tachycardia: Clinical Outcomes and Device Performance--The U.S. E-37 Trial
Q44565488Cerebellar volume is linked to cognitive function in temporal lobe epilepsy: a quantitative MRI study
Q33784884Cerebellum abnormalities in idiopathic generalized epilepsy with generalized tonic-clonic seizures revealed by diffusion tensor imaging
Q55396526Changes in Dynamics Within and Between Resting-State Subnetworks in Juvenile Myoclonic Epilepsy Occur at Multiple Frequency Bands.
Q35617456Circulating microRNAs are promising novel biomarkers for drug-resistant epilepsy
Q47442842Clinical characteristics of patients with epilepsy in a specialist neuropsychiatry service
Q45326701Clinical risk factors for depressive symptoms in patients with epilepsy
Q35453495Comparative double blind clinical trial of phenytoin and sodium valproate as anticonvulsant prophylaxis after craniotomy: efficacy, tolerability, and cognitive effects
Q40628130Determinants of disease severity in adults with epilepsy: Results from the Neurological Diseases and Depression Study
Q44572281Determining minimally important change thresholds for the Seizure Severity Questionnaire (SSQ).
Q46716550Developing the Pediatric Refractory Epilepsy Questionnaire: a pilot study
Q77794013Development of a new seizure severity questionnaire: initial reliability and validity testing
Q48366186Dissociative experiences and quality of life in patients with non-epileptic attack disorder
Q41678104Dynamic Susceptibility Contrast Enhanced (DSC) MRI Perfusion and Plasma Cytokine Levels in Patients after Tonic-clonic Seizures
Q37778625Effect of antiepileptic drugs on the postictal state. A critical overview
Q49962031Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): A randomized controlled trial.
Q89620651Evaluating the Effectiveness and Cost-Effectiveness of Seizure Dogs in Persons With Medically Refractory Epilepsy in the Netherlands: Study Protocol for a Stepped Wedge Randomized Controlled Trial (EPISODE)
Q41642476Evaluation of drug treatment outcome in epilepsy: a clinical perspective
Q35917748Fish Oil Intake and Seizure Control in Children with Medically Resistant Epilepsy
Q33909481Help seeking and suicidality among people with epilepsy in a rural low income country setting: cross-sectional survey
Q43514403Increased ratio of glutamate/glutamine to creatine in the right hippocampus contributes to depressive symptoms in patients with epilepsy
Q48099918Is antiepileptic drug withdrawal status related to quality of life in seizure-free adult patients with epilepsy?
Q43420360Marital adjustment for patients with epilepsy in China
Q33929669Measuring quality of life in epilepsy surgery patients.
Q35216352Measuring the efficacy of antiepileptic drugs
Q47876046Microstructural Alterations in Asymptomatic and Symptomatic Patients with Spinocerebellar Ataxia Type 3: A Tract-Based Spatial Statistics Study
Q34312710Monotherapy trials: endpoints
Q42691383Parents' caregiving approaches: facing a new treatment alternative in severe intractable childhood epilepsy
Q51891737Prevalence, patterns, service needs, and assessment of neuropsychiatric disorders among people with epilepsy in residential care: validation of the Neuropsychiatric Inventory as a caregiver-rated measure of neuropsychiatric functioning in epilepsy.
Q38144479Psychiatric adverse effects of zonisamide in patients with epilepsy and mental disorder comorbidities
Q91949099Quality of Life and Its Determinants in Adult Drug Refractory Epilepsy Patients Who Were Not Candidates for Epilepsy Surgery: A Correlational Study
Q53577848Quality of life research in adults with epilepsy in Japan.
Q34156372Quantitative assessment of seizure severity for clinical trials: a review of approaches to seizure components
Q33801753Research into the (Cost-) effectiveness of the ketogenic diet among children and adolescents with intractable epilepsy: design of a randomized controlled trial.
Q30275879Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials.
Q33929659Seizure control as an indicator of therapeutic usefulness
Q47446258Seizure outcomes in patients with anti-NMDAR encephalitis: A follow-up study
Q42630077Sensitivity testing of the Seizure Severity Questionnaire (SSQ).
Q89236217Sexual dysfunction and associated factors in Chinese Han women with epilepsy
Q92602905Social impairment and stigma in genetic generalized epilepsies
Q34214261Standards for epidemiologic studies and surveillance of epilepsy
Q50571737The MCT-ketogenic diet as a treatment option in refractory childhood epilepsy: A prospective study with 2-year follow-up.
Q48058067The Personal Impact of Epilepsy Scale (PIES).
Q53186000The effect of seizure severity on quality of life in epilepsy.
Q38104378The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs
Q48477097The ketogenic diet as a treatment option in adults with chronic refractory epilepsy: efficacy and tolerability in clinical practice
Q30674774The promise of new antiepileptic drugs
Q38784526Understanding the Patient Perspective of Seizure Severity in Epilepsy: Development of a Conceptual Model
Q33864984VEP indices of cortical lateral interactions in epilepsy treatment
Q48390407VNS in patients with previous unsuccessful resective epilepsy surgery: antiepileptic and psychotropic effects
Q48056576What is in a number? The Personal Impact of Epilepsy Scale (PIES).
Q81817716n-3 fatty acids (fish oil) for epilepsy, cardiac risk factors, and risk of SUDEP: clues from a pilot, double-blind, exploratory study

Search more.